| Primary |
| Parkinson's Disease |
45.0% |
| Prolactinoma |
19.6% |
| Hyperprolactinaemia |
7.7% |
| Pituitary Tumour Benign |
4.8% |
| Restless Legs Syndrome |
4.0% |
| Ill-defined Disorder |
2.8% |
| Drug Use For Unknown Indication |
2.7% |
| Product Used For Unknown Indication |
2.0% |
| Pituitary Tumour |
1.8% |
| On And Off Phenomenon |
1.5% |
| Asthma |
1.2% |
| Blood Prolactin Increased |
1.1% |
| Galactorrhoea |
0.8% |
| Insomnia |
0.8% |
| Parkinsonism |
0.8% |
| Prolactin-producing Pituitary Tumour |
0.8% |
| Acromegaly |
0.7% |
| Headache |
0.7% |
| Menstruation Irregular |
0.7% |
| Adenoma Benign |
0.6% |
|
| Mitral Valve Incompetence |
13.5% |
| Tricuspid Valve Incompetence |
9.1% |
| Pathological Gambling |
8.7% |
| Cerebrospinal Fluid Rhinorrhoea |
7.8% |
| Pneumocephalus |
7.8% |
| Intracranial Hypotension |
5.2% |
| Aortic Valve Incompetence |
4.8% |
| Abortion Spontaneous |
4.3% |
| Pleural Effusion |
4.3% |
| Interstitial Lung Disease |
3.9% |
| Pituitary Haemorrhage |
3.9% |
| Visual Pathway Disorder |
3.9% |
| Drug Ineffective |
3.5% |
| Visual Field Defect |
3.0% |
| Vomiting |
3.0% |
| Cardiac Valve Disease |
2.6% |
| Mitral Valve Disease |
2.6% |
| Nausea |
2.6% |
| Parkinson's Disease |
2.6% |
| Pleural Fibrosis |
2.6% |
|
| Secondary |
| Parkinson's Disease |
50.0% |
| Prolactinoma |
14.2% |
| Pituitary Tumour Benign |
6.0% |
| Restless Legs Syndrome |
4.8% |
| Pituitary Tumour |
4.6% |
| Hyperprolactinaemia |
3.4% |
| Blood Prolactin Increased |
1.9% |
| Hyperlipidaemia |
1.7% |
| Drug Use For Unknown Indication |
1.4% |
| Hypertension |
1.4% |
| Ill-defined Disorder |
1.4% |
| Posture Abnormal |
1.4% |
| Psychiatric Symptom |
1.4% |
| Convulsion |
1.0% |
| On And Off Phenomenon |
1.0% |
| Product Used For Unknown Indication |
1.0% |
| Adenoma Benign |
0.9% |
| Depression |
0.9% |
| Epilepsy |
0.9% |
| Galactorrhoea |
0.9% |
|
| Pathological Gambling |
8.5% |
| Vomiting |
8.5% |
| Umbilical Hernia |
7.5% |
| Cerebrospinal Fluid Rhinorrhoea |
6.6% |
| Visual Pathway Disorder |
6.6% |
| Back Pain |
4.7% |
| Neutropenia |
4.7% |
| Persecutory Delusion |
4.7% |
| Pituitary Haemorrhage |
4.7% |
| Somnolence |
4.7% |
| Thrombosis |
4.7% |
| Visual Field Defect |
4.7% |
| Gait Disturbance |
3.8% |
| Nausea |
3.8% |
| Neoplasm Progression |
3.8% |
| Personality Disorder |
3.8% |
| Retroperitoneal Fibrosis |
3.8% |
| Secondary Hypothyroidism |
3.8% |
| Torticollis |
3.8% |
| Blepharospasm |
2.8% |
|
| Concomitant |
| Parkinson's Disease |
27.0% |
| Product Used For Unknown Indication |
24.4% |
| Hypertension |
5.9% |
| Parkinsonism |
5.9% |
| Hiv Infection |
5.2% |
| Multiple System Atrophy |
4.4% |
| Drug Use For Unknown Indication |
4.1% |
| Acromegaly |
4.0% |
| Rheumatoid Arthritis |
3.6% |
| Depression |
2.8% |
| Pituitary Tumour |
2.0% |
| Hyperprolactinaemia |
2.0% |
| Diabetes Mellitus |
1.6% |
| Nervous System Disorder |
1.2% |
| Pituitary Tumour Benign |
1.1% |
| Assisted Fertilisation |
1.0% |
| Hypothyroidism |
1.0% |
| Asthma |
0.9% |
| Headache |
0.9% |
| Hypopituitarism |
0.9% |
|
| Somnolence |
12.1% |
| Tremor |
7.9% |
| Inappropriate Antidiuretic Hormone Secretion |
6.4% |
| Pulmonary Embolism |
5.7% |
| Loss Of Consciousness |
5.0% |
| Urinary Tract Infection |
5.0% |
| Weight Decreased |
5.0% |
| Weight Increased |
5.0% |
| Drug Ineffective |
4.3% |
| Malaise |
4.3% |
| Pain |
4.3% |
| Renal Cyst |
4.3% |
| Suicidal Ideation |
4.3% |
| Syncope |
4.3% |
| Wheezing |
4.3% |
| Agranulocytosis |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Nausea |
3.6% |
| Pain In Extremity |
3.6% |
| Urinary Incontinence |
3.6% |
|
| Interacting |
| Post-traumatic Epilepsy |
29.6% |
| Prolactinoma |
23.5% |
| Parkinson's Disease |
14.8% |
| Respiratory Tract Infection |
9.9% |
| Pneumonia |
7.4% |
| Vulvovaginal Mycotic Infection |
7.4% |
| Hyperprolactinaemia |
2.5% |
| Vaginal Lesion |
2.5% |
| Pituitary Tumour |
1.2% |
| Smoking Cessation Therapy |
1.2% |
|
| Psychotic Disorder |
18.8% |
| Diplopia |
12.5% |
| Mucosal Dryness |
12.5% |
| Osteonecrosis |
12.5% |
| Presyncope |
12.5% |
| Abnormal Behaviour |
6.3% |
| Drug Interaction |
6.3% |
| Nausea |
6.3% |
| Orthostatic Hypotension |
6.3% |
| Psychomotor Hyperactivity |
6.3% |
|
